AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ALTRI.PA

Trilogiq S.A. (ALTRI.PA) fair value

Industrials · Business Equipment & Supplies · Euronext Paris · France
€4.84+0.00%
Market cap €17MNext earnings 2024-05-13Updated Oct 22, 2026
Our verdict
Trades 9% below our fair value
Price
€4.84
Model fair valueConfidence: good
€5.32
Model range
€2.88 to €7.03
Fair value €5.32
Price €4.84
3 models fit Trilogiq S.A. and they disagree: 0 of 3 land within 15% of the average.
Two or more of our models back this value.
Near fair value(i)Bronze45
Valued as a mature, profitable company: Discounted cash flow, EV/EBITDA comparison, and Graham number.
ACCE opinionTrilogiq S.A. (ALTRI.PA)
Fair value (3 models)
€5.32
ACCE price target
€5.00
Rating
Fairly valued
Horizon
12 months
Fair value published on 22 Oct 2026, 13:04 CEST.
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Rating published on 22 Oct 2026, 13:04 CEST.
Price used: €4.84 at the close on 22 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
9.0% below
+9.9% to fair value
ACCE score
46
out of 100
P/E
25.5x
forward 13.8x
1-year return
-7.8%
Dividend yield
0.00%

Trilogiq S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

I don't have a reliable description of Trilogiq's specific products from the data provided, so I can't tie the thesis to what the company actually sells, and I won't guess at its product lineup. What the numbers show is a sub-20 million euro business equipment and supplies company with a 61.8% gross margin but only a 2.2% operating margin, which points to heavy operating costs absorbing most of the gross profit. Revenue fell 8.3%, and a 1.9% ROE on a 25.5x trailing P/E against a 13.8x forward P/E implies earnings are expected to recover sharply, a claim worth testing against the company's filings before anything else. Nothing in the data indicates an index membership or a near-term catalyst, so the case for a deeper look rests entirely on whether that margin recovery is credible. Given the size and the thin profitability, the first question is whether the gross margin is structural or a sign of a high-cost model that could be fixed.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ALTRI.PA's valuation models land
Price
€4.84
Model fair value
€5.32
Model range
€2.88 to €7.03
Fair value €5.32
Price €4.84
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-1.6%
1 month
-3.2%
3 months
-8.7%
6 months
-7.8%
YTD
-8.7%
1 year
-7.8%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€5.00first publication€4.84
22 Oct 2026, 13:04 CESTRatingFairly valuedfirst publication€4.88
22 Oct 2026, 13:04 CESTFair value€5.32first publication€4.88

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ALTRI.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth43Value47Quality54Momentum40Total46
Valuation
Trailing P/E
25.5x
Forward P/E
13.8x
PEG
0.10
P/B
0.45x
EV / Revenue
0.0x
Book value/sh
€9.19
Enterprise value
€-9,577,120
Profitability
ROE
1.9%
FCF yield
12.13%
ROIC
1.6%
Health and risk
Debt / equity
0.00
Dividend yield
0.00%
Beta
0.56

Price

-8.7% · 1Y

Ask anything about ALTRI.PA

Answered from Trilogiq S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 25% of peers
low 6.6x25.5xhigh 31.9x
ROEbetter than 50% of peers
low -78%2%high 6%
Div yieldbetter than 67% of peers
low 0.0%0.0%high 4.8%

Peers

Prices Oct 22, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ALTRI.PA Trilogiq S.A.€4.84€59% below25.5x1.9%5446
PRIC-B.ST Pricer AB (publ)kr 4.28kr 2170% above8.4x6.4%4858
GEA.PA Grenobloise d'Electronique et d'Automatismes Société Anonyme€68.00€638% above22.1x6.2%6745
SACI.PA Fiducial Office Solutions€36.00--31.9x-4.6%3950
EHGO Eshallgo Inc. Class A Ordinary Shares$2.67----77.7%3539
ALEXA.PA Exacompta Clairefontaine S.A.€147.00€21732% below6.6x4.6%5159
TTK.DE TAKKT AG€2.63----30.7%3533

Sector report card

Where ALTRI.PA ranks against its sector peers on each metric.

Computing percentiles…